Green Bioactives, a pioneering biotechnology company based in Scotland, has been recognised as one of the top ten platform technologies in the Inpart R&D Trends and Innovations Report 2025.
The report highlights the most promising biotech innovations based on industry engagement, sentiment of comments, commercial potential, and partnering activity. Green Bioactives secured its place thanks to strong interest from personal care and cosmetics companies looking for sustainable, science-backed ingredient solutions.
The company’s Plant Cell Culture Technology is transforming the way natural ingredients are sourced. By offering a sustainable, scalable, and ethical alternative to traditional wild harvesting, it provides a consistent, high-purity supply of plant-derived bioactives without the environmental and ethical challenges of conventional sourcing methods, enabling the beauty and personal care industries to have the freedom to develop innovate products.
With the global beauty and personal care market projected to generate revenue of $677.19 billion this year, with an expected annual growth rate of 3.37% from 2025 to 2030,the need for reliable and sustainable ingredient sourcing has never been greater.
Dr David McElroy, CEO of Green Bioactives, commented: "We are honoured to be recognised in this global report, which showcases the most exciting biotech innovations of the year. Consumers and brands are more focused than ever on sustainability and supply chain security. Our plant cell culture platform offers a reliable way to produce high-quality bioactives without the challenges of climate change, land use, or biodiversity loss.
“Being recognised in this report highlights the value of our innovation and its potential to reshape how natural ingredients are sourced for the personal care and cosmetics sector."
Green Bioactives is actively working with industry and academic partners to bring its plant cell culture-derived ingredients to market. The company is seeking new commercial partnerships to help brands integrate sustainable, plant-based bioactives into next-generation formulations.
The report can be downloaded here
